Skip to main content
. 2013 Mar 25;19(1):29–35. doi: 10.3350/cmh.2013.19.1.29

Figure 2.

Figure 2

Changes in serum HBV DNA levels from baseline during the treatment period in the ETV monotherapy group, and the LAM+ADV and ETV+ADV combination therapy groups.